C4 Therapeutics Inc. (CCCC) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    C4 Therapeutics Inc.

    NASDAQ: CCCC · Real-Time Price · USD
    2.73
    0.09 (3.41%)
    At close: Sep 11, 2025, 3:59 PM
    2.71
    -0.73%
    After-hours: Sep 11, 2025, 07:07 PM EDT

    C4 Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 55.5M 126.59M 29.75M 76.12M
    Short-Term Investments
    		 189.41M 127.09M 246.4M 233.16M
    Long-Term Investments
    		 22.36M 28.01M 60.96M 142.2M
    Other Long-Term Assets
    		 6.1M 6.17M 4.8M 3.82M
    Receivables
    		 3.1M 11.8M 1.47M 5.72M
    Inventory
    		 n/a n/a -60.96M n/a
    Other Current Assets
    		 9.76M 5.71M 70.89M n/a
    Total Current Assets
    		 257.77M 271.19M 287.56M 325.69M
    Property-Plant & Equipment
    		 63.38M 71.09M 77.52M 35.05M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 91.83M 105.26M 143.28M 181.08M
    Total Assets
    		 349.6M 376.45M 430.84M 506.76M
    Account Payables
    		 1.33M 1.45M 1.17M 4.51M
    Deferred Revenue
    		 18.71M 15.47M 16.62M 31.8M
    Short-Term Debt
    		 n/a 5.22M 2.29M 1.33M
    Other Current Liabilities
    		 9.3M 8.07M 3.11M 7.19M
    Total Current Liabilities
    		 45.18M 42.77M 44.55M 51.25M
    Long-Term Debt
    		 n/a n/a 9.2M 10.77M
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 88.44M 87.57M 97.06M 65.91M
    Total Liabilities
    		 133.62M 130.34M 141.61M 117.16M
    Total Debt
    		 65.76M 70.98M 87.15M 42.88M
    Common Stock
    		 7K 6K 5K 5K
    Retained Earnings
    		 -633.7M -528.38M -395.89M -267.71M
    Comprehensive Income
    		 53K -127K -4.14M -775K
    Shareholders Equity
    		 215.99M 246.11M 289.23M 389.61M
    Total Investments
    		 211.76M 155.1M 307.36M 375.36M

    Add to Watchlist